4.4 Article

Cross-cultural adaptation and validation of diabetes-39 in Turkish patients with type 2 diabetes

Journal

DISABILITY AND REHABILITATION
Volume 45, Issue 26, Pages 4450-4456

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/09638288.2022.2149864

Keywords

Type 2 diabetes; quality of life; questionnaire; validity; reliability

Categories

Ask authors/readers for more resources

The aim of this study was to translate the Diabetes-39 quality of life scale (D-39) into Turkish and validate it for use in Turkish patients with type 2 diabetes. The Turkish version of D-39 (D-39-TR) showed good internal consistency and test-retest reliability, and it was correlated with other outcome measures.
PurposeTo translate Diabetes-39 quality of life scale (D-39) into Turkish, to accomplish a cross-cultural adaptation, to demonstrate validity and reliability of Turkish version (D-39-TR).MethodsA total of 214 patients with type 2 diabetes were included, with an average age of 52.59 +/- 14.83, a female/male ratio of 51/49%. Internal consistency and test-retest reliability were assessed by Cronbach's alpha coefficient and intraclass correlation coefficient (ICC), respectively. For structural validity, factor analysis was used. The SF-36 was used for convergent validity, and hemoglobin A1c (HbA1c) was used for differential validity.ResultsThe Cronbach's alpha coefficient was over 0.70 for all subscales of D-39-TR and it was 0.93 for whole D-39-TR. No problematic items were detected in the scale. The ICC for test-retest reliability was 0.91 (95% CI 0.91-0.94). The test-retest consistency for the total score was r = 0.94, p < 0.001. D-39-TR was explained by five factors. The ratio of explaining the total variance of these 5 factors was determined as 53.97%. SF-36 (r=-0.48, p < 0.001) and HbA1c values (r = 0.31, p < 0.001) were moderately correlated with total score of D-39-TR. A significant difference was found between QoL values of patients with poor and good glycemic control (p < 0.001).ConclusionTurkish version of D-39 is a reliable and valid scale for measuring QoL in patients with type 2 diabetes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available